Press release -

Artificial Intelligence, Leadership and Lifelong Learning

Vironova COO Maria Homman was recently involved in staging a seminar and debate at IVA (The Royal Swedish Academy of Engineering Sciences) as part of the IFG Leadership Development program. Based on current and fascinating subjects of artificial intelligence, leadership and lifelong learning, the subjects for the day was 'AI the new leader in a digitized world?'.

The participants could enjoy an interesting debate on leadership and AI by panel discussion members

  • Elena Fersman, Director, Machine Intelligence and Automation Research Ericsson
  • Fredrik Heintz, Associate Professor at Linköpings University and member of EUs High Level Expert Group on AI
  • Peter Larsson, Senior Advisor Sveriges Ingenjörer
  • Kristina Lovén Seldén, Investigator, TCO
  • Ishtar Touailat, Head of Innovation Incubation at Tieto Data-Driven Business

About the Royal Swedish Academy of Engineering Sciences IFG Leadership Program

The program is based on collegial learning and study visits to members’ companies, providing the participants with deep insights into R&D processes and public authorities’ function in different sectors.

The IFG members all have leadership responsibility in research and development and each represent a unique field within the group. Together they largely cover areas considered of strategic importance for the future of Swedish industry.

- Participating in this program is a truly invaluable experience for me in my role as COO of Vironova. There are so many impressions, contacts and valuable lessons that I believe the whole company will benefit in various ways, and over a long time, from what I can bring home from these study visits, says Maria Homman.

Topics

  • Medical research

Categories

  • leadership
  • artificial intelligence
  • vironova

Vironova is a Swedish biotechnology company providing comprehensive, hardware, software and services for the analysis of nanoparticles. Vironova revolutionizes access to transmission electron microscopy (TEM)-based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.

The Vironova offering comprises:

  • Cost effective, fast Electron Microscopy (EM) services enabled by the in-house developed Vironova Analyzing Software (VAS) designed for semi-automated nanoparticle analysis
  • Viral clearance testing performed in GLP and BSLIII certified laboratories
  • MiniTEM™, a bench-top Transmission Electron Microscope system designed for automated nanoparticle characterization. High-resolution images reveal particle morphologies that are transformed into accurate metrics.

Contacts

Josefina Nilsson

Press contact CEO